Predictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study

Field Value
Model ID09-047-03
Model NameLosartan Intervention For Endpoint (LIFE) Risk Score - Stroke
Pubmed ID20001655
First AuthorKjeldsen
JournalBlood Pressure
Year2009
TitlePredictors of cardiovascular events in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention for Endpoint reduction in hypertension study
Primary Index ConditionPopulation Sample
Secondary Index ConditionHypertension
OutcomeStroke
Model Sample Size8465
Cohort Sample Size8465
Number of Events443
Follow-Up DurationLong (>6 months)
AUROC0.704
Calibration Reported1
CovariatesAge in non-smokers (per 10 years); Current smoker; Log urinary albumin:creatinine ratio (per 10-fold); History of atrial fibrillation; History of diabetes; Serum uric acid (per 10 umol/l); LVH by Sokolow-Lyon voltage (per 10 mm); Age in current smokers (per 10 years)
Mesh TermsTo be updated
Number of Validations0

External Validations